Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

BS_QV51J756

Ganglioglioma

e4acd5ea-c873-5960-a893-99a85e58ce75

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
Ganglioglioma
cancer_type_detailed
subtype
cancer_type
Ganglioglioma
overall_survival_months
17.608409986859396
age_years
9.512
sex
Male

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: Request returned HTTP 429 for HTTP HEAD to 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/brain-umap/2/gsva.parquet' LINE 1: SELECT pathway_library_id, pathway_name, gsva_score FROM read_parquet('https://pub-e056b053afc04eec88337b62541f3025... ^

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

3 twins match this tumor's tissue · 7 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1BS_ZR96A4FH
brain-umap@2
DNET0.986
2BS_C7N3J4NW
brain-umap@2
high-grade glioma0.965
3BS_6MY8W3H0
brain-umap@2
DNET0.964
4BS_7B89YR6K
medullo-epn-umap@date-based
EPNPosterior Fossa EPN0.963
5BS_92VDQ0NE
brain-umap@2
Ganglioglioma0.962
6BS_KPT2WPHW
brain-umap@2
Ganglioglioma0.961
7BS_7B89YR6K
brain-umap@2
Posterior Fossa Ependymoma0.960
8SRR1472323
brain-umap@2
GTEX0.957
9BS_K5802F84
brain-umap@2
pilocytic astrocytoma0.955
10BS_QF5VVZX5
brain-umap@2
Ganglioglioma0.950

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 14 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.460Remibrutinib— uncovered
PANCREAS_BETA_CELLS0.350Cobimetinib— uncovered
APICAL_SURFACE0.317Temsirolimus— uncovered
MYOGENESIS0.307Inavolisib— uncovered
HEDGEHOG_SIGNALING0.261Inavolisib— uncovered
SPERMATOGENESIS0.221Inavolisib— uncovered
BILE_ACID_METABOLISM0.166Inavolisib— uncovered
ESTROGEN_RESPONSE_EARLY0.158Inavolisib— uncovered
ESTROGEN_RESPONSE_LATE0.153Idelalisib— uncovered
COAGULATION0.121Binimetinib— uncovered
XENOBIOTIC_METABOLISM0.112Inavolisib— uncovered
APICAL_JUNCTION0.082Inavolisib— uncovered
KRAS_SIGNALING_UP0.057Inavolisib— uncovered
INFLAMMATORY_RESPONSE0.004Idelalisib— uncovered